Tuesday, April 24, 2012

Hearing Targets “Report On Carcinogens”


Dow, one of the manufactures of Agent Orange, invited to Congressional hearing.

(WASHINGTION, DC) – The Report on Carcinogens (ROC) is a congressionally mandated, science-based, public health report that identifies agents, substances, mixtures, or exposures in the environment that put people at increased risk for cancer.

Published biennially, each edition of the report is cumulative and consists of substances newly reviewed in addition to those listed in previous editions. The latest edition was published on June 10, 2011. The 13th ROC is under development.

Most Americans concerned about the health effects of environmental exposures and the increased risk of cancer would no doubt agree that the ROC is worthy effort to fund.

The ROC is not in the same category as the ‘bridge to nowhere’ or funding for the sexual life of bees. This is a serious scientific report that identifies environmental exposures that increase our risk of cancer.

The House of Representatives Small Business Subcommittee on Healthcare & Technology hearing is scheduled for Wednesday, April 25th. The subject is: “How the Report on Carcinogens Uses Science to Meet its Statutory Obligations and its Impact on Small business Jobs.”

Given the high unemployment rate and the small business engine that generates jobs, something that impacts small business jobs would naturally be of interest to Congress. But, targeting a scientific report that identifies environmental carcinogens is beyond the pale.

No comments:

Post a Comment